ALBANJI, M. H., SURBAYA, S. H., & ALNAKHLI, O. A. (2025). IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION. TPM – Testing, Psychometrics, Methodology in Applied Psychology, 32(S1 (2025): Posted 12 May), 738–744. Retrieved from https://tpmap.org/submission/index.php/tpm/article/view/249